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Abstract
The cellular environment of the CNS is non-permissive for growth and regeneration. In the retina, transplantation
of stem cells has been limited by inefficient survival and integration into existing circuits. In November 2016, as
part of the National Eye Institute’s Audacious Goals Initiative (AGI), a diverse collection of investigators gathered
for a workshop devoted to articulating the gaps in knowledge, barriers to progress, and ideas for new approaches
to understanding cellular environments within the retina and how these environments may be manipulated. In
doing so, the group identified the areas of (1) retinal and optic nerve glia, (2) microglia and inflammation, and the
(3) extracellular matrix (ECM) and retinal vasculature as key to advancing our understanding and manipulation of
the retinal microenvironments. We summarize here the findings of the workshop for the broader scientific
community.
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Introduction
The era of cell transplantation and neuroregeneration is
today becoming more science than science fiction. The
formation of laminated retinal organoids in culture (Meyer
et al., 2009, 2011; Eiraku et al., 2011; Zhong et al., 2014;
Shirai et al., 2016; Wiley et al., 2016; Reichman et al.,
2017; Wahlin et al., 2017) and stem cell transplantation
studies are increasingly commonplace. However, the next
vital step is to integrate these cells efficiently into a neural
circuit or microenvironment supporting a circuit that is
otherwise losing function. A way to control the cellular
environment to promote transplanted cell survival, differ-
entiation, and integration into the surviving retinal circuitry
may be most important for the success of regenerative
medicine. To tackle the question of how to create a
cellular environment for neuroregeneration, workshop
participants were charged to consider (1) the role of as-
trocytes and microglia as positive or negative mediators in
regeneration and synapse formation, (2) the importance of
vasculature and extracellular matrix (ECM) in regenera-
tion, and (3) the use of scaffolds and other extrinsic tools
to support regeneration and reconnection of retinal neu-
rons.
To begin to address these issues, it is first important to
recognize some of the unique features of the retina and its
place in the posterior eye that present physical barriers
and create distinct areas within the neural tissue that
define unique environmental subcompartments (Fig. 1),
especially with regard to lamination of the retinal tissue.
For example, the distal-most, or outermost layer of the
retina is comprised of rod and cone photoreceptors,
whose survival and disk morphogenesis depends inti-
mately on the overlying retinal pigment epithelial (RPE)
cells, the retinal choroid plexus, and beyond these, a very
important component of the blood-retinal barrier (BRB),
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Figure 1. Schematic of local microenvironments within the retina, based on a fixed vibratome section of a mouse retina expressing
a viral construct (Shh10-GFAP-mCherry) driving mCherry expression in Müller glial cells (red). Microglia (green) are localized in the
synaptic layers between the outer nuclear layer (ONL) and inner nuclear layer (INL) as well as the ganglion cell layer (GC). The
subretinal space is subtended by RPE cells (beige) and the ELM secreted by the Müller cells. The Müller cells also secrete the matrix
constituting the ILM, which serves as a barrier at the vitreoretinal surface. Astrocytes (blue) are abundant in the nerve fiber layer, where
they interact extensively with GCs and blood vessels (bv, orange).
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Bruch’s membrane. The proximal retina likewise has a
clear anatomical barrier, the internal limiting membrane
(ILM), which is composed of collagen and other ECM
components secreted by the Müller cell endfeet, which
keep the ionic and protein milieu of the CNS distinct from
that of vitreous, a boundary known as the vitreo-retinal
surface. Further, the optic nerve head, where unmyeli-
nated ganglion cell axons exit the eye in forming the nerve
proper, also presents challenges to regeneration. These
include age-related changes in the inflammatory microen-
vironment, especially with regard to microglia, astrocytes,
bioenergetic capacity, and oxidative stress.
Within this context, we will first discuss the state of the
science regarding retinal glia (Müller cells and astrocytes),
the role of resident immune cells (microglia) and neuroin-
flammation, and the functions of the ECM and BRB. Then
we will consider the current best strategies and greatest
barriers for progress in these areas. It was clear from the
workshop that an improved understanding of how these
cells and niches maintain the retinal environment, and
how injury and disease perturbs those functions, will en-
able more successful transplantation and neuroregenera-
tion. Thus, this report adds an additional perspective to
those of the previous four Audacious Goals Initiative (AGI)
workshops and highlights areas for researchers to ad-
dress for manipulating the cellular environment so that
regenerative strategies have maximal effectiveness.
Results
Retinal glia
Glial cells are classically considered the support cells of
the nervous system because of their essential role in
providing nutrients and growth factors, structural support,
maintenance and regulation of the blood-brain and BRB
and tissue homeostasis. Glia are particularly adept at
sensing and responding to microenvironmental changes.
For example, glial expression of aquaporins and TRP
channels (Jo et al., 2015) transduce mechanical stress
into intracellular calcium signaling and ECM remodeling
(Ryskamp et al., 2014; Choi et al., 2015). In recent years,
glia have also emerged as active participants capable of
refining circuit properties through gliotransmission, pro-
motion of synaptogenesis, synaptic plasticity, and mod-
ulation of blood flow through vasoconstriction/dilation in
response to changes in electrical activity (Newman, 2015;
Giannoni et al., 2018). Elsewhere in the nervous system
they also sustain myelination (oligodendrocytes and
Schwann cells) and in some instances prevent or impede
axon regeneration, either through pro-inflammatory sig-
naling or formation of glial scars (Adams and Gallo, 2018).
The two most abundant glial cell types of the retina,
Müller cells and astrocytes, have distinct morphological
and physiological characteristics. Müller cells uniquely
span all of the retinal layers, from the ILM created by their
endfeet at the vitreoretinal surface to the adhesion junc-
tions they make with each other just distal to the outer
nuclear layer, called the outer limiting membrane. The
distinct, specialized microenvironments of the retina and
the subretinal space are unique in their ECM and ionic
composition, which the Müller cells help to maintain. Mül-
ler cells shuttle potassium ions from the photoreceptors at
outer limiting membrane to the vitreoretinal surface, and
are essential for maintaining the accompanying changes
in osmotic balance (for review, see Sarthy and Ripps,
2001; Bringmann et al., 2006). The intimate contacts be-
tween Müller cells and cone photoreceptors also permits
retinoid exchange that helps to maintain visual pigment
and cone signaling in bright light (Xue et al., 2015). Unlike
glia elsewhere in the brain, Müller cells are deficient in
pyruvate kinase and rely on metabolites from photorecep-
tors and other retinal neurons to fuel their mitochondria,
one of their many metabolic oddities needed to sustain
the demanding outer retinal environment (for review, see
Hurley et al., 2015). Müller glia may hold the secret to
unlocking neuroregenerative capacity in the retina since
they themselves can divide and produce neural progeni-
tors throughout adulthood in fish (Lenkowski and Ray-
mond, 2014) and after injury in chicken (Fischer and
Bongini, 2010). This neurogenic state has recently been
successfully induced in mice through the ectopic expres-
sion in Müller cells of the proneural transcription factor
Ascl1 (Jorstad et al., 2017).
Retinal astrocytes are found only in the ganglion cell
and nerve fiber layers (Büssow, 1980), where they help to
control neural activity, contribute to the integrity of the
BRB, and regulate vascular tone (for review, see MacVicar
and Newman, 2015). Astrocytes form close contacts with
the unmyelinated segments of retinal ganglion cell (RGC)
axons, where they may play a particularly important role in
supporting the unique metabolic demands of RGCs
(Calkins, 2013). Astrocytes show phagocytic activity (for
review, see Clarke and Barres, 2013) both in development
and in adulthood, with those in the optic nerve head
maintaining the extracellular environment by constitui-
tively phagocytosing axons and organelles (Nguyen et al.,
2011), including RGC mitochondria (Davis et al., 2014).
Because Müller cells are also known for the phagocytic
activity (for recent review, see Bejarano-Escobar et al.,
2017), both of these classes of retinal (Müller) and optic
nerve (astrocyte) glia likely contribute to debris scaveng-
ing and microenvironmental homeostasis on an even
larger scale than previously appreciated, mimicking to
some extent the actions of immune cells that enter the
diseased CNS. Failure of these phagocytic roles for glia
may promote cell or axon loss over time or inhibit the
regenerative capacity of the microenvironment.
In retinal degeneration, like elsewhere in the CNS, glia
undergo morphologic changes including stages of hyper-
trophy and changes in gene expression in a process
collectively known as gliosis. Increased expression of the
intermediate filament protein, glial filamentous acidic pro-
tein (GFAP), is a common hallmark of a late stage of
gliosis, but we now appreciate that complex molecular
mechanisms likely precede and initiate these profound
cellular changes. Gliosis in other parts of the CNS has
both adaptive and maladaptive functions. Adaptive func-
tions include regulation and restriction of inflammation
and modulation of excitatory activity, whereas maladap-
tive effects can interfere with the ability of glia to perform
their homeostatic functions, making the modulation of
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different aspects of gliosis a potential therapeutic target
(Sofroniew, 2015). More study is needed about such
mechanisms in the retina, optic nerve head, and optic
nerve proper.
Despite the abundance and central role of glia in retinal
health and disease, there are few diseases known to
directly result from glial defects. One possible exception
is idiopathic juxtafoveolar retinal telangiectasis [also
known as macular telangiectasia type 2 (MacTel-2); Gass
and Blodi, 1993]. The histopathology of retinas from
MacTel-2 patients has demonstrated loss of Müller cells
in affected retinal regions (Powner et al., 2010, 2013) ; the
mechanistic cause and consequence of these changes
remains unknown.
Microglia and neuroinflammation
In seeking a better understanding of retinal microenvi-
ronments and how to manipulate them, there is perhaps
no better place to start than endogenous immune cells.
Microglia, the resident immune cells of the CNS, con-
stantly surveil their local microenvironment, extending
and retracting their branched processes primarily within
the synaptic layers of the retina. In response to changes in
the immediate milieu (cytokines, complement, extracellu-
lar ions like potassium released from damaged cells),
microglia transform into migratory, ameboid-shaped cells
with greater phagocytic capacity, often referred to as an
“activated” state. Activated microglia rapidly respond to
sites of injury/degeneration where they engulf stressed or
dying cells and debris. In reality, there is an entire spec-
trum of microglial morphologies between ramified and
amoeboid microglial states, making morphologic catego-
rization of limited utility when trying to quantify the degree
of neuroinflammation, particularly in chronic diseases with
on-going slow degeneration and resolution of inflamma-
tion in neighboring regions. Histologically it is sometimes
also difficult to discern whether apparent engulfment of
neurons by microglia is a manifestation of the high rate of
phagocytosis that activated microglia typically display, or
whether such contacts might sometimes be providing
neurotrophic support. Newly developed approaches for
single-cell RNA sequencing, transcriptional and epig-
enomic profiling of rodent and human microglia, such as
DropSeq, is revealing molecular signatures that may help
identify specific functional states in health and disease
(Butovsky et al., 2014; Matcovitch-Natan et al., 2016;
Gosselin et al., 2017; Keren-Shaul et al., 2017).
Microglia, like macrophages, can take on either helpful
or harmful roles under different conditions, and the sig-
naling mechanisms that mediate these transitions are
poorly understood. In healthy CNS tissue, microglia
perform homeostatic and physiologic functions that are
crucial for CNS development and for regulating neuro-
plasticity in the adult. For example, ramified microglia
prune unneeded synaptic contacts during development
(Paolicelli et al., 2011; Schafer et al., 2012) and mediate
experience-dependent plasticity in the visual system
(Tremblay et al., 2010). In the healthy adult retina, ablation
of microglia leads to a reduction in synaptic transmission
and ultrastructural inclusions within photoreceptor synap-
tic terminals, revealing an essential role for microglia in
synaptic maintenance in the retina (Wang et al., 2016).
Conversely, inappropriate activation of microglia medi-
ates loss of synapses in a mouse model of Alzheimer’s
disease (Hong et al., 2016) and related diseases (Lui et al.,
2016; Vasek et al., 2016), reinforcing the view that micro-
glia are homeostatic, microenvironmental biosensors for
the CNS.
Interactions between microglia, astroglia, and blood
vessels likely help to globally modulate the cellular envi-
ronment. The Barres Lab (Liddelow et al., 2017) recently
showed that when activated, microglia upregulate a num-
ber of factors that include TNF-, IL1, and C1q; these
molecules in turn cause astrocytes to assume a toxic “A1”
state in which they produce other factors, as yet uniden-
tified, that lead to the death of RGCs. Simultaneous de-
letion of the genes encoding these factors or antibodies
binding to their protein product lead to strong neuropro-
tection of RGCs after injury to the optic nerve. Surpris-
ingly, however, another group recently reported that
deletion of microglia with the drug PLX5622 does not alter
RGC fate after optic nerve injury (Hilla et al., 2017), sug-
gesting that cells other than microglia might also produce
the factors responsible for transforming astrocytes. These
findings underscore the importance of increasing our un-
derstanding of the cellular interactions involving microglia,
other inflammatory cells, and astrocytes after CNS dam-
age.
All neurodegeneration appears to involve microglia
(Hanisch and Kettenmann, 2007), which can further esca-
late the immune response by signaling monocytes to
extravasate from retinal vessels and migrate to the site of
injury. Once in the retinal environment, monocytes rapidly
stop expressing some characteristic monocytic markers,
like CCR2, and instead express microglial markers
(O’Koren et al., 2016), making it difficult to distinguish the
fates of these two cell populations during the course of
degeneration. These infiltrative neutrophils and macro-
phages express a host of trophic and cytotoxic factors, of
which the small Ca2-binding protein oncomodulin plays
a particularly important role in promoting axon outgrowth
(Yin et al., 2006). In age-related macular degeneration
(AMD) and photoreceptor degeneration, the accumulation
of phagocytes in the subretinal space and surrounding
drusen can alter the inhibitory, immunosuppressive nature
of the microenvironment, leading to disease progression
(for review, see Guillonneau et al., 2017). Until recently, it
was thought that there was very little turnover of microglia
in the healthy CNS over an organism’s lifespan. However,
a recent study reported on-going apoptosis and compen-
satory proliferation (replacement) of microglia in the adult
brain (Askew et al., 2017). The differential functions of
microglia and monocyte/macrophages in chronic degen-
erative disease, in age-related susceptibility to disease,
and in inflammation following an acute insult is an intense
area of research in the CNS in general (Baufeld et al.,
2017).
Because microglia play a role in synapse elimination as
well as neurodegeneration, they may contribute to synap-
tic reorganization after transplantation. After optic nerve
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injury, the survival of RGCs and/or regeneration of their
axons is suppressed by the accumulation of mobile zinc in
the terminals of amacrine cells and subsequent exocytotic
transfer of this zinc to RGCs (Li et al., 2017). During
development, RGCs lose their intrinsic ability for robust
axonal growth coincident with the time they receive syn-
aptic inputs from interneurons, and cell culture studies
suggest that physical contact between RGCs and ama-
crine cells, the inhibitory interneurons of the retina, play a
role (Goldberg et al., 2002a,b). Thus, it may be worth
investigating whether synapse elimination or reorganiza-
tion via microglia or other phagocytic cells normally oc-
curs after optic nerve damage.
The retinal ECM and the BRB
In the retina, the Müller glial cells are principally respon-
sible for the ECM barriers that construct distinct barriers
and microenvironments. Their distal endfeet secrete the
collagen-rich basement membrane that constitutes the
ILM along the vitreoretinal surface, while their most apical
processes envelope the photoreceptor inner segments
and form adherens junctions between themselves, form-
ing the external limiting membrane (ELM). Both the ILM
and ELM provide structural and diffusional barriers that
create microenvironment compartments for the inner and
outer retina, respectively (Fig. 1). Within the space be-
tween the RPE and ELM, a unique ECM known as the
interphotoreceptor matrix (IPM) helps to maintain photo-
receptor viability and alignment (Ishikawa et al., 2015).
Understanding the distinct composition of these compart-
ments could lead to the control of cell adhesion and
motility, affecting both degeneration, repair and regener-
ation following transplantation. Work in this area is very
promising: for example, hybrid scaffolds composed of
IPM component and synthetic biopolymers can influence
progenitor cell proliferation and promote differentiation
toward a photoreceptor-like fate (Baranov et al., 2014).
The molecular details of the matrix comprising the in-
terstitial space in the healthy retina is not well known,
though defects in components of the ECM are associated
with degeneration and/or functional deficits (for review,
see Al-Ubaidi et al., 2013). There may be heterogeneity
between the permissiveness of outer and inner retinal
matrices, since bipolar cell dendrites can sprout in aging
and disease, but RGCs do not. There is also heterogeneity
across the surface of the retina, with macular holes heal-
ing and filling in, whereas peripheral holes do not. The
basis for these differences is not known, but the ECM is
likely to be part of the equation.
The retinal blood supply stems from both inner and
outer vascular beds: the choriocapillaris, a system of
fenestrated capillaries that lies beyond the outer retina
and beyond the RPE and Bruch’s membrane, and the
retinal vessels emanating from the optic nerve head along
the inner retinal surface. The outer BRB is primarily
Bruch’s membrane and the tight-junctions between the
RPE cells, which prevent the unregulated passage of
cells, proteins and ions into the subretinal space. The
inner BRB relies on the tight junctions between the vas-
cular endothelial cells themselves, which are affected by
inflammation, glycation, and edema (Klaassen et al.,
2013). Like elsewhere in the CNS, blood flow and leakage
across the BRB is regulated by inner retinal astrocytes,
vascular pericytes and perivascular macrophages, and
BRB breakdown is associated with many chronic retinal
diseases. The molecular mechanisms that maintain a
healthy barrier and are affected in disease appear to be
somewhat different from those for the blood-brain barrier
and remain relatively understudied (Díaz-Coránguez et al.,
2017). Two of the most prevalent diseases of the retina,
wet AMD and diabetic retinopathy, lead to breaches of the
outer and inner BRB, respectively. Thus, the motivation
for understanding how the BRB is maintained and how it
might be restored in disease is very high.
Next steps
Many gaps and barriers currently limit our understand-
ing of retinal glia, microglia and inflammation, and the
ECM and BRB. First, the role of glia in regulating the
retinal microenvironment in both health and disease
needs additional study. For example, unlike glia else-
where in the CNS, there is very little known about the roles
of Müller cells at retinal synapses, of astrocytes signaling
with RGC axons, and of the normal rate of glial phagocy-
tosis or synaptic maintenance in healthy retina. Are there
subtypes or “states” of reactive astrocytes in the retina
that exert neurotoxic or neuroprotective effects like in the
brain (Liddelow et al., 2017)? Do retinal astrocytes control
glymphatic perfusion of the interstitial space like in the
brain (Jessen et al., 2015)? To what degree can neurore-
generation be augmented by targeting both astrocyte and
microglial activation states?
To tackle these questions as a field, additional tools and
resources are needed (Table 1). Although there are sev-
eral good markers for labeling Müller cells in the retina,
including a custom AAV called Shh10 (Klimczak et al.,
2009) that drives serotype-specific Müller cell transduc-
tion, there is a need for consistent analogous tools for
labeling or manipulating astrocytes exclusively in the liv-
Table 1. Specific recommendations from workshop partici-
pants
 Development of tools for labeling/manipulating astrocytes
in the living retina
 Gene expression profiling of glial cell types during gliosis
 A better understand of Müller cell roles in creating and
maintaining ECM and retinal health
 Examination of the transcription factors/signaling
mechanisms that control microglial state changes
 Methods to label resident and systemic immune cells
acutely in order to examine morphology during disease
(ideally suitable for use in humans)
 Further understanding of microglia signaling mechanisms
during aging and disease
 Methods to make transplanted cells less adherent to
CSPGs at scarred sites
 Further development of ECM scaffolds to promote
regeneration or integration of transplanted cells
 The ability to manipulate the blood-retina barrier in a
region-specific manner for targeted delivery of therapeutic
agents
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ing retina or optic nerve head. Gene expression profiling
of both glial cell types before and during degeneration will
help to define the sequence of signaling events that pre-
cede frank gliosis, and which may contribute to early loss
of neuronal function. Such expression profiling may help
to identify drug targets that could in turn be harnessed to
control glial function throughout disease progression,
both by boosting glial-based metabolic/neurotrophic
support and by delaying or reversing gliosis itself. Fi-
nally, a turn away from typical rodent-based model
systems could dramatically change our understanding
of Müller cell function, since Müller cells in lower ver-
tebrates readily regenerate or transform to a
progenitor-like state (Goldman, 2014). Emerging re-
search indicates a similar, though far more limited,
capacity in rodents, which we may learn to harness by
comparisons with lower vertebrates. Understanding
this regenerative power is the first step to harnessing its
potential for control of the microenvironment and im-
proving transplantation efficiency.
With regards to microglia, because they are motile and
dynamic in both form and function, they offer great po-
tential for cell transplantation and neuroregeneration
fields. Since microglia are essential for reinforcing and
sustaining proper synaptic connections in healthy tissue,
they perhaps could likewise be programmed to prune
away the stressed or damaged regions of the retina.
Achieving this will require a better understanding of the
transcription factors or signaling mechanisms that control
microglial state changes. Understanding these signaling
networks could also be harnessed to develop therapeu-
tics that could boost microglial support functions and
delay phagocytic transformation. Developing such re-
agents is challenging, in part because of the very nature of
microglia’s sensitivity to their environment: microglia
steadily transform ex vivo into an activated phenotype. To
study microglia in vivo, high-resolution retinal imaging
methods like adaptive-optics scanning laser ophthalmos-
copy (AO-SLO) can resolve microglial morphology and
branch dynamics across different retinal layers in
Cx3CR1gfp/ mice (Zawadzki et al., 2015). While this ge-
netic approach in mice is experimentally convenient, it
would be better to label resident and systemic immune
cells acutely, which could then be applied to any species,
including human subjects in any state of retinal disease.
Unlike nearly all other cell types in the retina, to date there
are no known viral serotypes or nanoparticle tagging
methods that reliably reveal microglia within their native
environment. A better understanding of the signaling
mechanisms of microglia, and how they change in aging
and disease, might allow us to program resident cells to
migrate to and deliver support as needed.
Our understanding of the ECM in the retina is limited. As
in other tissues, deposition of chondroitin sulfate pro-
teoglycans (CSPGs) generally create sticky barriers
through which cells cannot readily migrate or axons read-
ily penetrate. In injury and disease, gliosis leads to dis-
ruption of ECM homeostasis and deposition of CSPGs
and other inhibitory glycans (neurocan, aggrecan, versi-
can), which will need to be overcome for transplantation
therapies to efficiently lead to cell migration, integration
and synaptogenesis (Lau et al., 2013). Currently, best
strategies for overcoming CSPGs is to simply digest with
matrix metalloproteinase-2 (MMP-2), though this non-
specific destruction might be problematic because some
matrix scarring can prevent the spread of damage. A
better alternative would be to make transplanted cells less
adherent to CSPGs, making them “blind” to the scarred
site.
Studies which define the properties of the interstitial/
ECM environment over the course of development and
aging could provide important clues to explain why adult
tissue is so anti-regenerative. The retina virtually explodes
with proliferation during development, with many more
neurons being born than are ultimately needed, creating a
wave of apoptosis and synaptogenesis that likely drives
up the phagocytic activity of glia and microglia alike. Can
we exploit the ECM/microenvironment of the developing
optic projection (nerve and retina) to better understand
why it is not permissive in adulthood? Can we harness the
latent regenerative capacity of Müller cells (Sifuentes
et al., 2016; Jorstad et al., 2017) or re-engage a
development-like state by tweaking the ECM where it is
needed during degeneration? Can we engineer specific
ECM scaffolds to promote regeneration or integration of
transplanted cells or to allow cell and process motility
while preserving the benefits of CSPG barriers to isolate
damaged areas? How can a healthy BRB be best sup-
ported throughout aging and disease? The ability to ma-
nipulate the ECM and the BRB in a region-specific
manner could be key to modulate glial reactivity and
neuroinflammation in disease, and to deliver therapeutic
agents from the bloodstream directly to regions of injury
and degeneration.
Summary
To optimize the cellular environment for neuroregenera-
tion and cell transplantation, much more basic knowledge
is needed about individual retinal niches, the composi-
tion of the interstitial spaces within the retina (e.g.,
ECM), the optic nerve head, and the optic nerve and
how these spaces are normally maintained by the BRB,
by glia, and by microglia. Comparisons of these niches
through the course of development and aging will in-
form us of candidate mechanisms to promote growth-
friendly environments for regeneration. Each of the
fields of study individually have specific needs and
strengths (Table 1), though clearly there is a need for
collaboration between experts within different niches to
accelerate discovery.
Several overarching principles readily emerged from the
group’s consideration of the state of the field in toto. First,
this general area woefully lacks the same depth of basic
mechanistic understanding enjoyed by some other fields.
Investigators should consider more basic science re-
search and fewer disease-based studies. The rationale for
this is that normal function of glia, microglia and the
neurovascular unit is likely to be similar across species,
whereas individual diseases may produce uniquely spe-
cific changes that render common mechanisms difficult to
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infer. Second, each retinal niche suffers from a paucity of
descriptive or cataloged definitions. For example, each
niche needs to address issues of cell-type specificity and
heterogeneity, and how these populations change during
development, aging and disease, in both animal models
and humans. DropSeq and other high-throughput meth-
ods that are often beyond the means of a single lab or
insufficiently hypothesis-driven for a typical individual in-
vestigator award are nonetheless vital for identifying the
building blocks on which new hypotheses for mechanism
can be generated.
Finally, such building blocks of knowledge would pre-
sumably lead to the development of new tools which are
vital for monitoring and controlling cellular environments.
New and better animal models are needed to bridge our
understanding from mice to humans. Centralized, man-
aged database repositories and a nationalized system for
donor tissue banks would facilitate resource and data
sharing in a manner that would ultimately save time and
money and promote collaboration. As one participant
pointed out, the field of neuroregeneration needs the
“optogenetics equivalent” for tweaking glia and microglia
to promote cell survival, tissue remodeling, and synap-
togenesis as needed. Through cross-fertilization of
fields, collaborative approaches, and investment of re-
sources in basic discovery science, manipulation of the
cellular environments to promote regeneration can
soon be a reality.
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